Nexstim Plc has received an order for an NBS System 5 from a distributor company based in Europe. Nexstim?s NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved for presurgical mapping of the speech and motor cortices of the brain. In addition to its motor and speech mapping features, this specific system also includes therapeutic capabilities that allow the system to be used for the treatment of major depression and chronic neuropathic pain.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 EUR | +1.35% | -0.44% | -23.13% |
Apr. 22 | Nexstim Wins Order for Navigated Brain Stimulation System in US | MT |
Apr. 22 | Nexstim Receives NBS 6 System Order from Clinic in Florida, US | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.13% | 16.32M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- NXTMH Stock
- News Nexstim Plc
- Nexstim Receives Nexstim NBS System 5 Order from Distributor in Europe